Nextech Invest logo

Nextech Invest

Crunchbase
Pitchbook
Crunchbase

Deals on record

5

Common Fundraising Type

Series C

Be Bio logo
Be Bio

Engineered B Cell Medicines

Nextech logo
Takeda Ventures logo
RA Capital Management logo
Longwood Fund logo
Bristol Myers Squibb logo
Atlas Venture logo
Arch Venture Partners logo
Alta Partners logo

Be Biopharma is developing engineered B cell medicines to produce therapeutic proteins for treating conditions like Hemophilia B and Hypophosphatasia.

Series C
$92M
01/15/2025
Article
Alpha-9 Oncology logo
Alpha-9 Oncology

Radiopharmaceuticals

Ascenta Capital logo
Lightspeed Venture Partners logo
Samsara BioCapital logo
RA Capital Management logo
Nextech Invest logo
Longitude Capital logo
General Catalyst logo
Digitalis Ventures logo

Alpha-9 Oncology Inc. develops targeted radiopharmaceuticals to improve cancer treatment.

Series C
$175M
10/23/2024
Article
Circle Pharma logo
Circle Pharma

Biopharmaceutical

The Column Group logo
Nextech Invest logo
Euclidean Capital logo

Circle Pharma is a biopharmaceutical company developing cell-permeable macrocycle treatments for cancer and other serious diseases.

Series D
$90M
09/03/2024
Article

Atavistik Bio is a biotech company developing precision allosteric therapeutics for oncology, leveraging proprietary screening technology and AI to discover new treatment sites on proteins or RNA.

Equity
$40M
12/19/2023
Article
Mariana Oncology logo
Mariana Oncology

Biotechnology

Forbion logo
Deep Track Capital logo
Surveyor Capital logo
RA Capital Management logo
Nextech Invest logo
Eli Lilly and Company logo
Atlas Venture logo
Access Biotechnology logo

Mariana Oncology is a biotechnology company that develops targeted peptide-based radiopharmaceuticals for the treatment of cancer, with a focus on delivering optimized radiation doses to solid tumors.

Series B
$175M
09/07/2023
Article